Assertive Community Treatment (ACT) in Schizophrenia Spectrum Disorders (ACCESS)
Schizophrenia
About this trial
This is an interventional treatment trial for Schizophrenia focused on measuring Schizophrenia, assertive community treatment, quetiapine
Eligibility Criteria
Inclusion Criteria:
- Age 18-65 years
- Met the diagnostic criteria of a first- or multiple episode of a schizophrenia spectrum disorders, i.e. schizophrenia, schizophreniform disorder, schizoaffective disorder, delusional disorder, or psychotic disorder NOS
- New initiation or current treatment with quetiapine Immediate Release (IR)
Exclusion Criteria:
- Other psychotic disorders (e.g., due to medical condition)
- Mental retardation (IQ lower than 70 points)
Sites / Locations
- University Medical Center Hamburg
Arms of the Study
Arm 1
Experimental
Standard care
Standard care comprised a treatment network consisting of open and closed inpatient wards, day-clinics, an outpatient centre, and eight private psychiatrists. Each patient was treated by a private psychiatrist or by a psychiatrist in the outpatient centre. Home visits were possible, but office visits were the general rule. Patients were allowed to use all treatment offers in the outpatient centre. Outside office hours, patients could refer themselves to the psychiatric hospital. Psychosocial treatments as supportive therapy, psychoeducation, psychotherapy, and family intervention were provided infrequently and in a less intensive and unsystematic way, and only in the minority of cases. This 'standard of care' definition is in accordance with other studies.